Progressive publishes new research
FY outlook confirmed with cost rises contained
Brick and concrete products manufacturer Forterra has confirmed it expects FY2021E results will be in line with management expectations as strong demand and price increases have offset input cost inflation. This should have a short-term impact on margins, but mitigated with increased revenue expectations. Looking to FY2022E and beyond, housebuilding volumes are predicted to keep growing, while we believe the Group's pricing power will be supported by industry-wide brick inventories falling to a 23-year low. |
Click here for full analysis
Subscribe to Progressive's research, which is freely available to every type of investor, and be kept informed about our regular programme of investor engagement.
About Progressive:
Progressive is an equity research and investor engagement company. FCA authorised and regulated, the firm has a 15-strong team of highly experienced analysts. We provide Institutional grade research and connect companies with investors across every sector of the market.
www.progressive-research.com
Broad coverage
| Analyst calibre
| |||
across 12 sectors |
|
|
| |
|
|
| ||
Business Services | Oil & Gas | 15 | with average | 20 |
Financials | Property | experience of | ||
Healthcare | Retail | |||
Industrials | Technology | 30+ | techMARK | |
Investment Trusts | Telecoms | industry based | Extel | |
Mining | Utilities | awards | StarMine |
For further information please contact:
Keith Hodgskiss
+44 (0) 20 7781 5315
Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.